GALLIVAC IBD S706 NEO
GALLIVAC IBD S706 NEO
Authorised
This information is not available for this product.
Product identification
Medicine name:
GALLIVAC IBD S706 NEO
Active substance:
This information is not available for this product.
Target species:
-
Chicken
Route of administration:
-
Ocular use
-
Oral use
-
Oculonasal use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
Ocular use
- Chicken
-
All relevant tissues0day
-
-
Oral use
- Chicken
-
All relevant tissues0day
-
-
Oculonasal use
- Chicken
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1847497 2/2019
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
How useful was this page?: